Buys
Open market- Shares
- Avg price
- Total value
Gabriel Brooks - Chief Medical Officer at Solid Biosciences Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- SLDB on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Gabriel Brooks in Solid Biosciences Inc.
Sells
Open market- Shares
- -43,846
- Avg price
- $6.41
- Total value
- -$280,915
Net
Past year- Shares
- -43,846
- Share %
- -100%
- Total value
- -$280,915
Reported holdings for Gabriel Brooks in Solid Biosciences Inc.
Form 4 holding
Chief Medical Officer
Solid Biosciences Inc.
- Security class
- Common Stock
- Shares / value
- 89,466
- Estimated value
- $520,987
- Report date
- 18 Feb 2026
- Price
- $5.82
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
Solid Biosciences Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 21,876
- Estimated value
- $129,939
- Report date
- 13 Feb 2026
- Price
- $3.96
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
Solid Biosciences Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 207,450
- Estimated value
- Report date
- 29 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
Solid Biosciences Inc.
- Security class
- Performance Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 29 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Gabriel Brooks in Solid Biosciences Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.